Literature DB >> 32703064

COVID-19 - Recent advancements in identifying novel vaccine candidates and current status of upcoming SARS-CoV-2 vaccines.

Mohd Iqbal Yatoo1, Zeenat Hamid2, Oveas Rafiq Parray1, Aasim Habib Wani1, Abrar Ul Haq1, Archana Saxena3, Shailesh Kumar Patel4, Mamta Pathak4, Ruchi Tiwari5, Yashpal Singh Malik6, Ranjit Sah7, Ali A Rabaan8, Alfonso J Rodriguez Morales9,10, Kuldeep Dhama4.   

Abstract

The COVID-19 pandemic caused by SARS-CoV-2 has spread rapidly. To date, countries have relied on the prevention of the disease through isolation, quarantine, and clinical care of affected individuals. However, studies on the roles of asymptomatic and mildly infected subjects in disease transmission, use of antiviral drugs, and vaccination of the general population will be very important for mitigating the effects of the eventual return of this pandemic. Initial investigations are ongoing to evaluate antigenic structures of SARS-CoV-2 and the immunogenicity of vaccine candidates. There also is a need to comprehensively compile the details of previous studies on SARS-related vaccines that can be extrapolated to identify potent vaccine targets for developing COVID-19 vaccines. This review aims to analyze previous studies, current status, and future possibilities for producing SARS-CoV-2 vaccines.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; pandemic; vaccines

Year:  2020        PMID: 32703064     DOI: 10.1080/21645515.2020.1788310

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  21 in total

Review 1.  A Scoping Insight on Potential Prophylactics, Vaccines and Therapeutic Weaponry for the Ongoing Novel Coronavirus (COVID-19) Pandemic- A Comprehensive Review.

Authors:  Priyanka Dash; Subhashree Mohapatra; Sayantan Ghosh; Bismita Nayak
Journal:  Front Pharmacol       Date:  2021-02-26       Impact factor: 5.810

2.  Improvement of the inactivated SARS-CoV-2 vaccine potency through formulation in alum/naloxone adjuvant; Robust T cell and anti-RBD IgG responses.

Authors:  Melika Haghighi; Akbar Khorasani; Pegah Karimi; Mehdi Mahdavi
Journal:  Iran J Basic Med Sci       Date:  2022-05       Impact factor: 2.532

Review 3.  Healthcare workers, epidemic biological risks - recommendations based on the experience with COVID-19 and Ebolavirus.

Authors:  Mia Edgar; Saranya A Selvaraj; Karen E Lee; Yohama Caraballo-Arias; Mason Harrell; Alfonso J Rodriguez-Morales
Journal:  Infez Med       Date:  2022-06-01

4.  Safety and Immunogenicity of mRNA Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Lung Cancer Receiving Immune Checkpoint Inhibitors: A Multicenter Observational Study in Japan.

Authors:  Makoto Hibino; Kiyoaki Uryu; Takayuki Takeda; Yusuke Kunimatsu; Shinsuke Shiotsu; Junji Uchino; Soichi Hirai; Tadaaki Yamada; Asuka Okada; Yoshikazu Hasegawa; Osamu Hiranuma; Yusuke Chihara; Riko Kamada; Shunichi Tobe; Kazunari Maeda; Shigeto Horiuchi; Tetsuri Kondo; Koichi Takayama
Journal:  J Thorac Oncol       Date:  2022-06-22       Impact factor: 20.121

5.  Recommendation and Roadmap of Mass Vaccination against Coronavirus Disease 2019 Pandemic in Bangladesh as a Lower-Middle-Income Country.

Authors:  M J Hossain; S M A Rahman; T B Emran; S Mitra; M R Islam; K Dhama
Journal:  Arch Razi Inst       Date:  2021-12-30

Review 6.  Stem cell therapies and benefaction of somatic cell nuclear transfer cloning in COVID-19 era.

Authors:  Birbal Singh; Gorakh Mal; Vinod Verma; Ruchi Tiwari; Muhammad Imran Khan; Ranjan K Mohapatra; Saikat Mitra; Salem A Alyami; Talha Bin Emran; Kuldeep Dhama; Mohammad Ali Moni
Journal:  Stem Cell Res Ther       Date:  2021-05-12       Impact factor: 6.832

7.  Immunomodulatory effects of zinc and its impact on COVID-19 severity.

Authors:  Manish Dhawan; Talha Bin Emran; Om Prakash Choudhary
Journal:  Ann Med Surg (Lond)       Date:  2022-04-16

Review 8.  Diverse Immunological Factors Influencing Pathogenesis in Patients with COVID-19: A Review on Viral Dissemination, Immunotherapeutic Options to Counter Cytokine Storm and Inflammatory Responses.

Authors:  Ali A Rabaan; Shamsah H Al-Ahmed; Mohammed A Garout; Ayman M Al-Qaaneh; Anupam A Sule; Raghavendra Tirupathi; Abbas Al Mutair; Saad Alhumaid; Abdulkarim Hasan; Manish Dhawan; Ruchi Tiwari; Khan Sharun; Ranjan K Mohapatra; Saikat Mitra; Talha Bin Emran; Muhammad Bilal; Rajendra Singh; Salem A Alyami; Mohammad Ali Moni; Kuldeep Dhama
Journal:  Pathogens       Date:  2021-05-07

Review 9.  Inside the story about the research and development of COVID-19 vaccines.

Authors:  Shrina P Patel; Gayatri S Patel; Jalpa V Suthar
Journal:  Clin Exp Vaccine Res       Date:  2021-05-31

10.  Vaccination status, acceptance, and knowledge toward a COVID-19 vaccine among healthcare workers: a cross-sectional survey in China.

Authors:  Xiao-Hong Li; Lin Chen; Qi-Ni Pan; Juan Liu; Xu Zhang; Jing-Jing Yi; Chun-Mei Chen; Qiu-Hu Luo; Pin-Yue Tao; Xiao Pan; Su-Yu Lu; Liang-Zhong Liu; Hui-Qiao Huang
Journal:  Hum Vaccin Immunother       Date:  2021-08-03       Impact factor: 4.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.